Anika Therapeutics, Inc. (ANIK)
15.14
+0.02
(+0.13%)
USD |
NASDAQ |
May 07, 16:00
15.14
0.00 (0.00%)
After-Hours: 16:58
Anika Therapeutics SG&A Expense (TTM) : 53.95M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| TELA Bio, Inc. | 78.88M |
| BioCryst Pharmaceuticals, Inc. | 266.18M |
| Masimo Corp. | 386.60M |
| Lantheus Holdings, Inc. | 453.81M |
| Evolus, Inc. | 164.15M |